DCCCX
Price
$25.76
Change
-$0.36 (-1.38%)
Updated
Nov 14 closing price
VSCIX
Price
$119.32
Change
-$1.38 (-1.14%)
Updated
Nov 14 closing price
Ad is loading...

DCCCX vs VSCIX

Header iconDCCCX vs VSCIX Comparison
Open Charts DCCCX vs VSCIXBanner chart's image
Delaware Small Cap Core C
Price$25.76
Change-$0.36 (-1.38%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index I
Price$119.32
Change-$1.38 (-1.14%)
VolumeN/A
CapitalizationN/A
DCCCX vs VSCIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCCCX vs. VSCIX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCCCX is a StrongBuy and VSCIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 151B vs. DCCCX (8.02B). VSCIX pays higher dividends than DCCCX: VSCIX (1.43) vs DCCCX (0.00). DCCCX was incepted earlier than VSCIX: DCCCX (19 years) vs VSCIX (27 years). DCCCX is a more actively managed with annual turnover of: 26.00 vs. VSCIX (12.00). DCCCX has a lower initial minimum investment than VSCIX: DCCCX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 32.13 vs. DCCCX (24.38). VSCIX return over 5 years is better than : 59.15 vs. DCCCX (30.34).
DCCCXVSCIXDCCCX / VSCIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years27 years-
Gain YTD15.57518.40485%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.02B151B5%
Annual Yield % from dividends0.001.43-
Returns for 1 year24.3832.1376%
Returns for 3 years-10.557.14-148%
Returns for 5 years30.3459.1551%
Returns for 10 years35.62128.6328%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHVS20.150.31
+1.56%
Pharvaris NV
BOX34.670.43
+1.26%
BOX
TSCO278.75-0.44
-0.16%
Tractor Supply Company
XGN2.75-0.04
-1.43%
Exagen
AMTX4.11-0.51
-11.04%
Aemetis